In this study, we observed a hypermethylation status of Bin1, which contributed to the attenuated Bin1 expression in ESCC cells, and the de-methylation agent Decitabine could restore the expression of Bin1 by reversing this hypermethylation. Here, BIN1 is linked to esophageal squamous cell carcinoma.